Document:

ex_192287.htm

Exhibit 10.1

 

 

Supply Contract

 

between

 

 

The Coretec Group Inc.

6804 South Canton Avenue, Suite 150, Tulsa, OK 74136

U.S.A.

- "Customer" -

 

and

 

Evonik Resource Efficiency GmbH 

Rodenbacher Chaussee 4, 63457 Hanau

Germany

 

- "Evonik" -

 

 

- Customer and Evonik individually referred to as "Party" and collectively as "Parties" -

 

 

Preamble

 

Customer is a developer of technology-based solutions for application within a number of global markets, including energy storage, solid state lighting, printable electronics, microelectronics, solar energy, and 3D imaging within the medical and cyber security markets, and

 

Evonik is a leading manufacturer of specialty chemicals such as functional silanes, and

 

Customer has a need for the Products (as defined herein) and Evonik is willing to supply the Products to Customer.

 

Therefore, in this supply contract, Customer and Evonik wish to set out the terms and conditions that shall apply to each individual purchase.

 

 

 

 

Section 1     Subject Matter; Applicable Terms

 

 

	 	
			(1)

				
			The subject matter of this supply contract is the sale and delivery of the products as set forth in in Annex 1 ("Product(s)") by Evonik to Customer.

			

 

	 	
			(2)

				
			Any individual sale and purchase transaction for the sale and delivery of Products shall be exclusively governed by the terms of this supply contract including the Annexes, the general conditions of sale and delivery as set forth in Annex 2 and the applicable law; in case of a conflict between the GTC and the terms of this supply contract including the other Annexes, the latter shall prevail.

			

 

Section 2     Product Quality and Safety; Handling of the Products; Trade Restrictions

 

	 	
			(1)

				
			Upon delivery, the Product shall comply with the specifications as set out in Annex 1. Such specifications are the final and exclusive description of the quality and all the properties of the Products.

			

 

	 	
			(2)

				
			Customer shall observe the instructions regarding the technical handling of the Products including but not limited to Evonik's Responsible Care regulations to be found at Evonik's website and the safety data sheet of the Product as attached in Annex 3 ("Safety Data Sheet"). Customer is responsible for handling the Product with due care and shall ensure that the handling, transport, storing, sale and distribution (if applicable), disposal (if applicable) of the Products ("Handling of the Products") by the relevant Service Provider (as defined below) shall comply with all applicable laws and regulations.

			

 

	 	
			(3)

				
			Customer shall furthermore ensure that the Products are sold together with all accompanying documents necessary and required under the law applicable in the territory where the Products are sold. This includes but is not limited to all data which must be made available to the customers with regard to product safety and product liability, in particular but not limited to the Safety Data Sheet.

			

 

	 	
			(4)

				
			The Customer shall furthermore ensure that its customers are capable of Handling the Products and Handling of the Cylinders per the Safety Data Sheet and that its customers accept all liability for handling the Products and the Cylinders safely upon and during their possession and return the Cylinders back to the Customer undamaged in any way. For the avoidance of doubt, nothing contained herein shall affect Customer's responsibility vis- a-vis Evonik for proper and safe Handling of the Product and Handling of the Cylinders.

			

 

	 	
			(5)

				
			The Customer shall not use, sell or otherwise dispose of any of the Products (i) for the development or production of biological, chemical or nuclear weapons, (ii) for the unlawful manufacture of drugs, (iii) in violation of embargoes, (iv) in violation of any legal registration or notification requirement, or without having obtained all relevant approvals required under applicable laws and regulations.

			

 

- 2 -

 

 

Section 3     Product Quantity; Packaging; Handling of the Cylinders

 

	 	
			(1)

				
			The Products will be delivered in cylinders (bubblers) with a capacity of 50g each ("Cylinders"). The Cylinders are and shall remain the property of Evonik. Customer may use the Cylinders only for the purpose of unloading, storage and transport of Products and may only store the Cylinders at qualified sites in Ann Arbor, Ml or Southeast Ml. Customer shall handle the Cylinders with due care.

			

 

	 	
			(2)

				
			Promptly after the entire consumption of the Products stored therein, Customer shall engage a Service Provider (as defined below) to prepare the Cylinders for the return to Evonik including but not limited to the emptying, cleaning, storing and transport of the Cylinders in compliance with all applicable laws and regulations ("Handling of the Cylinders"). Before return to Evonik, Customer shall certify to Evonik that the Cylinder are properly emptied and cleaned and shall ensure that the relevant Service Provider confirms proper Handling of the Cylinders by executing and submitting a cleaning and inspection protocol substantially in the form as set out in Annex 4 to Evonik. Customer shall through the relevant Service Provider deliver the Containers empty and in good condition DDP (lncoterms 2020) to the Evonik site in Germany as designated by Evonik as soon as possible without undue delay but at the latest within twelve (12) months after delivery pursuant to Section 4. Customer may not retain (and waives any right to retain) any Container for whatever reason.

			

 

	 	
			(3)

				
			If a Cylinder is lost or gets substantially damaged, Customer shall pay USO 3,000 per Cylinder to Evonik as damage payment. Other potential legal claims shall not be affected.

			

 

Section 4     Service Providers for Handling of Products and Cylinders

 

	 	
			(1)

				
			Due to the specific qualities of the Products and the associated risks, Customer shall engage one or several reputable and certified service providers as defined in Annex 5 ("Service Provider(s)") to carry out the Handling of the Products, including but not limited to the storage, transport to the end customers of Customer and the disposal of any Products left over in the Cylinders upon return by the end customers, as well as the Handling of the Cylinders.

			

 

	 	
			(2)

				
			Upon request by Evonik, Customer shall provide proof of the engagement of the relevant Service Providers. Furthermore, Customer shall ensure that the relevant Service Provider provides Evonik with written and detailed confirmation of proper Handling of the Products and/or the Cylinders to the extent set out herein or otherwise upon Evonik's request, in particular but not limited to the Service Provider certifying that they are qualified to transport the Products and the Cylinders starting from Evonik's site (EXW) and store the Products and the Cylinders in certified storage facilities, in each case per the Safety Data Sheet and all applicable laws and regulations.

			

 

- 3 -

 

 

	 	
			(3)

				
			Evonik shall be entitled upon its sole discretion to directly contact the relevant Service Provider in order to inspect proper Handling of the Products and/or Cylinders, however, it remains the sole responsibility of Customer to monitor and ensure proper Handling of the Products and the Cylinders by the relevant Service Provider.

			

 

	 	
			(4)

				
			The Customer's failure to comply with the obligations set forth above in Sections 2 to 4 shall entitle Evonik to terminate this Agreement for good cause with immediate effect. Evonik's right to terminate shall be without prejudice to any other right or remedy of Evonik in respect of the breach. The Customer shall indemnify Evonik against, and hold it harmless from, any claims, damages, costs, expenses, liabilities, loss, claims or proceedings whatsoever arising out of, or in connection with, any breach by the Customer of its obligations set forth in Sections 2 to 4.

			

 

Section 5     Process and Terms of Ordering; Delivery Terms

 

	 	
			(1)

				
			Customer shall issue purchase orders in writing, specifying the Product quantity and the place of delivery with a lead-time of six (6) months, unless otherwise as set out in Annex 1, prior to the desired delivery date. Customer's purchase orders will become binding as soon as Evonik confirms such orders in writing. If applicable, Customer's purchase orders shall be spread as evenly as possible over each calendar year.

			

 

	 	
			(2)

				
			Risk to the Products shall pass in accordance with the delivery terms (lncoterms 2020) agreed in Annex 1.

			

 

	 	
			(3)

				
			Section 13 of the GTC shall apply, however, the time to submit any claims for defects and delivery shortfalls shall start as of delivery of the Products to the end customer of the Customer, or, in the case of latent defects, as of the time the end customer discovers or should have discovered it through reasonable inspection. Customer shall prove to Evonik the date of such delivery and timely investigation, if requested by Evonik.

			

 

Section 6     Prices and Payment Terms

 

	 	
			(1)

				
			The prices for the Products are set forth in Annex 1. All prices shall be exclusive of the current value added tax (VAT). Evonik shall invoice VAT separately, if applicable.

			

 

	 	
			(2)

				
			Customer shall pay invoices according to the payment terms set forth in Annex 1. Customer shall make payments to a bank account indicated on the invoice.

			

 

	 	
			(3)

				
			Payment shall be deemed made upon the unconditional receipt of payment into the bank account of Evonik as indicated in the relevant invoice.

			

 

- 4 -

 

 

Section 7     Confidentiality

 

Any technical information or business information discussed with the other Party or disclosed in writing or orally under and with respect to this Agreement shall be treated as information exchanged under and thus to be treated pursuant to the terms of the Mutual Secrecy and Evaluation Agreement entered into by the Parties and effective as of 4 December 2019.

 

Section 8     Term

 

	 	
			(1)

				
			This supply contract shall retroactively enter into force on 1 April 2020 and shall be valid until 31 March 2021. Either Evonik or the Customer may terminate this supply contract by giving not less than three months' notice of termination in written form.

			

 

	 	
			(2)

				
			Either Evonik or the Customer may terminate this supply contract for good cause by giving notice in written form, in particular, in the event (i) that the other party commits a material breach of this supply contract and fails to remedy such within sixty (60) days after the date of notice in written form from the non-breaching party setting out the nature of the breach and demanding that the same be remedied, (ii) of an application for insolvency in relation to the assets of the other party, commencement of insolvency proceedings in relation to the assets of the other party, or the refusal of such for lack of remaining assets.

			

 

	 	
			(3)

				
			Neither expiration nor termination of this supply contract shall release any Party from any outstanding obligations incurred by it prior to any such expiration or termination.

			

 

Section 9     Entirety/ Severability / Written form

 

	 	
			(1)

				
			This Supply Contract contains the complete understanding between the Parties with regard to the subject matter herein. No oral supplements have been made to this Supply Contract. Any amendments to the Supply Contract shall be made in writing and signed by each Party.

			

 

	 	
			(2)

				
			Should a provision or any part of a provision be or become void, illegal or unenforceable, the validity of the remaining provisions shall in no way be affected. In such case the Parties shall negotiate in good faith a substitute provision being commercially equivalent to the void and/or illegal and/or unenforceable provision or provisions.

			

 

 

[Signature page following]

 

- 5 -

 

 

 

	____________             _________________	 	____________             _________________
	Place                                Date 	 	Place                                Date 
	 	 	 
	The Coretec Group Inc.	 	Evonik Resource Efficiency GmbH
	 	 	 
	 	 	 
	_________________________	 	____________________          ____________________
	
			Michael Kraft

			Chief Executive Officer

				 	
			[Name]                                          [Name]

			[Title]                                            [Title]

			

 

 

 

	Annex 1:	 	Products, Specifications, Prices and Delivery and Payment Terms
	Annex 2:	 	General Terms and Conditions
	Annex 3:	 	Safety Data Sheet
	Annex 4:	 	Cleaning and Inspection Protocol
	Annex 5:	 	Service Providers

 

 

 

 

- 6 -Exhibit 10.1

 

 

BARCLAYS CAPITAL
INC.

  

$150,000,000 

 

Enviva Partners,
LP

Enviva Partners Finance
Corp.

 

6.500% Senior Notes
due 2026

 

Purchase Agreement

 

                                                                                                           June
29, 2020

 

Barclays Capital Inc.

As Representative of the

several Initial Purchasers listed

in Schedule 1 hereto

 

c/o Barclays Capital Inc.

745 Seventh Avenue

New York, New York 10019

 

Ladies and Gentlemen:

 

Enviva Partners, LP, a Delaware
limited partnership (the “Partnership”), and Enviva Partners Finance Corp., a Delaware corporation (the “Finance
Corp.” and together with the Partnership, the “Issuers”) propose to issue and sell to the several
initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representative
(the “Representative”), $150,000,000 principal amount of its 6.500% Senior Notes due 2026 (the “Securities”).
The Securities will be issued pursuant to an Indenture dated as of December 9, 2019 (the "Indenture"), among
the Issuers, the guarantors listed in Schedule 2 hereto (the “Guarantors”) and Wilmington Trust, National Association,
as trustee (the “Trustee”), and will be guaranteed on an unsecured basis by each of the Guarantors (the “Guarantees”).
Enviva Partners GP, LLC, a Delaware limited liability company (the “General Partner”), serves as the general
partner of the Partnership.

 

The Securities constitute “Additional
Notes” (as such term is defined in the Indenture) and will be issued pursuant to and in compliance with the Indenture. The
Issuers have previously issued $600,000,000 aggregate principal amount of 6.500% Senior Notes due 2026 (the “Initial
Notes”) under the Indenture. Except as disclosed in the Time of Sale Information, the Securities will have terms identical
to the Initial Notes and will be treated as a single series of debt securities for all purposes under the Indenture.

 

    

     

    

 

The Issuers and the Guarantors
hereby confirm their agreement with the several Initial Purchasers concerning the purchase and resale of the Securities, as follows:

 

1.       Offering
Memorandum and Transaction Information.

 

The Securities will be sold to
the Initial Purchasers without being registered under the Securities Act of 1933, as amended (the “Securities Act”),
in reliance upon an exemption therefrom. The Issuers and the Guarantors have prepared a preliminary offering memorandum dated
June 29, 2020 (the “Preliminary Offering Memorandum”) and will prepare an offering memorandum dated the date
hereof (the “Offering Memorandum”) setting forth information concerning the Issuers, the Guarantors and the
Securities. Copies of the Preliminary Offering Memorandum have been, and copies of the Offering Memorandum will be, delivered
by the Issuers to the Initial Purchasers pursuant to the terms of this purchase agreement (the “Agreement”).
The Issuers hereby confirm that they have authorized the use of the Preliminary Offering Memorandum, the other Time of Sale Information
(as defined below) and the Offering Memorandum in connection with the offering and resale of the Securities by the Initial Purchasers
in the manner contemplated by this Agreement. Capitalized terms used but not defined herein shall have the meanings given to such
terms in the Preliminary Offering Memorandum. References herein to the Preliminary Offering Memorandum, the Time of Sale Information
and the Offering Memorandum shall be deemed to refer to and include any document incorporated by reference therein and any reference
to “amend,” “amendment” or “supplement” with respect to the Preliminary Offering Memorandum
or the Offering Memorandum shall be deemed to refer to and include any documents filed after such date and incorporated by reference
therein.

 

At or prior to the time when sales
of the Securities were first made (the “Time of Sale”), the Issuers had prepared the following information
(collectively, the “Time of Sale Information”): the Preliminary Offering Memorandum, as supplemented and amended
by the written communications listed on Annex A hereto.

 

The transactions contemplated by
this Agreement and the Indenture and the use of a portion of the net proceeds from the sale of the Securities to fund a portion
of the cash consideration for the acquisitions of the limited liability company interests in Georgia Biomass Holding, LLC and
the interests owned by Enviva Development Holdings, LLC in Enviva Pellets Greenwood Holdings II, LLC, to repay borrowings under
the Partnership’s senior secured revolving credit facility and for general Partnership purposes are collectively referred
to as the “Transactions.”

 

    2

     

    

 

2.       Purchase
and Resale of the Securities.

 

(a)       The
Issuers agree to issue and sell the Securities to the several Initial Purchasers as provided in this Agreement, and each Initial
Purchaser, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth
herein, agrees, severally and not jointly, to purchase from the Issuers the respective principal amount of Securities set forth
opposite such Initial Purchaser’s name in Schedule 1 hereto at a price equal to: 102.75% of the principal amount thereof,
plus accrued interest from July 15, 2020, if any. The Issuers will not be obligated to deliver any of the Securities except upon
payment for all the Securities to be purchased as provided herein.

 

(b)       The
Issuers understand that the Initial Purchasers intend to offer the Securities for resale on the terms set forth in the Time of
Sale Information. Each Initial Purchaser, severally and not jointly, represents, warrants and agrees that:

 

(i)       it
is a qualified institutional buyer within the meaning of Rule 144A under the Securities Act (a “QIB”) and an
accredited investor within the meaning of Rule 501(a) of Regulation D under the Securities Act (“Regulation D”);

 

(ii)       it
has not solicited offers for, or offered or sold, and will not solicit offers for, or offer or sell, the Securities by means of
any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving
a public offering within the meaning of Section 4(a)(2) of the Securities Act; and

 

(iii)       it
has not solicited offers for, or offered or sold, and will not solicit offers for, or offer or sell, the Securities as part of
their initial offering except:

 

(A)       to
persons whom it reasonably believes to be QIBs in transactions pursuant to Rule 144A under the Securities Act (“Rule
144A”) and in connection with each such sale, it has taken or will take reasonable steps to ensure that the purchaser
of the Securities is aware that such sale is being made in reliance on Rule 144A; or

 

(B)       in
accordance with the restrictions set forth in Annex C hereto.

 

(c)       Each
Initial Purchaser acknowledges and agrees that the Issuers and, for purposes of the “no registration” opinions to
be delivered to the Initial Purchasers pursuant to Sections 6(f) and 6(g), counsel for the Issuers and counsel for the Initial
Purchasers, respectively, may rely upon the accuracy of the representations and warranties of the Initial Purchasers, and compliance
by the Initial Purchasers with their agreements, contained in paragraph (b) above (including Annex C hereto), and each Initial
Purchaser hereby consents to such reliance.

 

(d)       The
Issuers acknowledge and agree that the Initial Purchasers may offer and sell Securities to or through any affiliate of an Initial
Purchaser and that any such affiliate may offer and sell Securities purchased by it to or through any Initial Purchaser.

 

    3

     

    

 

(e)       Payment
for and delivery of the Securities will be made at the offices of Latham & Watkins LLP (811 Main Street, Suite 3700, Houston,
Texas, 77002) at 10:00 A.M., New York City time, on July 15, 2020, or at such other time or place on the same or such other date,
not later than the fifth business day thereafter, as the Representative and the Issuers may agree upon in writing. The time and
date of such payment and delivery is referred to herein as the “Closing Date.”

 

(f)       Payment
for the Securities shall be made by wire transfer in immediately available funds against delivery to the nominee of The Depository
Trust Company (“DTC”), for the account of the Initial Purchasers, of one or more global notes representing
the Securities (collectively, the “Global Note”), with any transfer taxes payable in connection with the sale
of the Securities duly paid by the Issuers. The Global Note will be made available for inspection by the Representative not later
than 1:00 P.M., New York City time, on the business day prior to the Closing Date.

 

(g)       The
Issuers and the Guarantors acknowledge and agree that each Initial Purchaser is acting solely in the capacity of an arm’s
length contractual counterparty to the Issuers and the Guarantors with respect to the offering of Securities contemplated hereby
(including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent
of, the Issuers, the Guarantors or any other person. Additionally, neither the Representative nor any other Initial Purchaser
is advising the Issuer, the Guarantors or any other person as to any legal, tax, investment, accounting or regulatory matters
in any jurisdiction. The Issuers and the Guarantors shall consult with their own advisors concerning such matters and shall be
responsible for making their own independent investigation and appraisal of the transactions contemplated hereby, and neither
the Representative nor any other Initial Purchaser shall have any responsibility or liability to the Issuers or the Guarantors
with respect thereto. Any review by the Representative or any Initial Purchaser of the Issuer, the Guarantors, and the transactions
contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Representative
or such Initial Purchaser, as the case may be, and shall not be on behalf of the Issuers, the Guarantors or any other person.

 

3.       Representations
and Warranties of the Issuers and the Guarantors. The Issuers and the Guarantors jointly and severally represent and warrant
as of the Time of Sale and as of the Closing Date to each Initial Purchaser that:

 

(a)         
Preliminary Offering Memorandum, Time of Sale Information and Offering Memorandum. The Preliminary Offering Memorandum,
as of its date, did not, the Time of Sale Information, at the Time of Sale, did not, and at the Closing Date, will not, and the
Offering Memorandum, in the form first used by the Initial Purchasers to confirm sales of the Securities and as of the Closing
Date, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Issuers
and the Guarantors make no representation or warranty with respect to any statements or omissions made in reliance upon and in
conformity with information relating to any Initial Purchaser furnished to the Issuers in writing by such Initial Purchaser through
the Representative expressly for use in the Preliminary Offering Memorandum, the Time of Sale Information or the Offering Memorandum.

 

    4

     

    

 

(b)         
Additional Written Communications. The Issuers and the Guarantors (including their agents and representatives, other
than the Initial Purchasers in their capacity as such) have not prepared, made, used, authorized, approved or referred to and
will not prepare, make, use, authorize, approve or refer to any written communication that constitutes an offer to sell or solicitation
of an offer to buy the Securities (each such communication by the Issuers and the Guarantors or their agents and representatives
(other than a communication referred to in clauses (i), (ii) and (iii) below) an “Issuer Written Communication”)
other than (i) the Preliminary Offering Memorandum, (ii) the Offering Memorandum, (iii) the documents listed on Annex A hereto,
including a term sheet substantially in the form of Annex B hereto, which constitute part of the Time of Sale Information, and
(iv) any electronic road show or other written communications, in each case used in accordance with Section 4(c) hereof. Each
such Issuer Written Communication, when taken together with the Time of Sale Information at the Time of Sale, did not, and at
the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided
that the Issuers and the Guarantors make no representation or warranty with respect to any statements or omissions made in each
such Issuer Written Communication in reliance upon and in conformity with information relating to any Initial Purchaser furnished
to the Issuers in writing by such Initial Purchaser through the Representative expressly for use in any Issuer Written Communication.

 

(c)         
Incorporated Documents. The documents incorporated by reference in each of the Time of Sale Information and the
Offering Memorandum, when they were filed with the Commission, conformed or will conform, as the case may be, in all material
respects to the requirements of the Exchange Act, and the rules and regulations of the Commission thereunder, and did not and
will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

		(d)	Financial Statements.

 

(i)       The
financial statements and the related notes thereto of Enviva Partners, LP and its subsidiaries included or incorporated by reference
in each of the Time of Sale Information and the Offering Memorandum present fairly in all material respects the financial position
of the Partnership and its subsidiaries (collectively, the “Partnership Entities”) as of the dates indicated
and the results of their operations and the changes in their cash flows for the periods specified; such financial statements have
been prepared in conformity with generally accepted accounting principles (“GAAP”) applied on a consistent
basis throughout the periods covered thereby, except to the extent disclosed therein; and the other financial information included
or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum has been derived from the accounting
records of the Partnership Entities and presents fairly in all material respects the information shown thereby.

 

    5

     

    

 

(ii)       The
historical financial statements and related notes of Enviva Wilmington Holdings, LLC (“Wilmington Holdings”) and its
subsidiaries required by Rule 3-05 of Regulation S-X incorporated by reference in the Time of Sale Information and the Offering
Memorandum were audited, as described therein, by KPMG LLP and present fairly in all material respects the financial position
of Wilmington Holdings and its subsidiaries as of the dates indicated and the results of their operations and the changes in their
cash flows for the periods specified; such financial statements have been prepared in conformity with GAAP applied on a consistent
basis throughout the periods covered thereby, except to the extent disclosed therein.

 

(iii)       The
pro forma financial statements incorporated by reference in the Time of Sale Information and the Offering Memorandum have been
prepared in accordance with the applicable accounting requirements of Regulation S-X under the Securities Act, the assumptions
used in preparing the pro forma financial statements incorporated by reference in the Time of Sale Information and the Offering
Memorandum provide a reasonable basis for presenting the significant effects directly attributable to the transactions or events
described therein, the related pro forma adjustments give appropriate effect to those assumptions, and the pro forma columns therein
reflect the proper application of those adjustments to the corresponding historical financial statement amounts.

 

(iv)       The
interactive data in eXtensible Business Reporting Language included or incorporated by reference in each of the Preliminary Offering
Memorandum, the Time of Sale Information and the Offering Memorandum fairly presents the information called for in all material
respects and is prepared in accordance with the Commission's rules and guidelines applicable thereto.

 

(e)         
No Material Changes. Except as described in the Time of Sale Information and the Offering Memorandum, since the
date of the latest audited financial statements of the Partnership included or incorporated by reference in the Time of Sale Information
and the Offering Memorandum (i) the Partnership Entities have not sustained any material loss or interference with their business
from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental
action, order or decree, (ii) the Partnership Entities have not issued or granted any securities, (iii) the Partnership Entities
have not incurred any material liability or obligation, direct or contingent, other than liabilities and obligations that were
incurred in the ordinary course of business, (iv) the Partnership Entities have not entered into any material transaction not
in the ordinary course of business, and (v) there has not been any material change in the partnership or limited liability company
interests, as applicable, or long-term debt of the Partnership Entities, or any development involving a Material Adverse Effect.
For purposes of this Agreement, “Material Adverse Effect” refers to an adverse change, in or affecting the
condition (financial or otherwise), results of operations, members’ equity/partners’ capital, properties, management,
business or prospects of the Partnership Entities, taken as a whole, in each case except as would not, in the aggregate, reasonably
be expected to have a material adverse effect on the condition (financial or otherwise), results
of operations, members’ equity or partners’ capital, properties, business or prospects of the Partnership Entities,
taken as a whole.

 

    6

     

    

 

(f)          
The Issuers and the General Partner. Each of the Issuers and the General Partner have been duly organized, is validly
existing and in good standing as a limited partnership, corporation or limited liability company, as applicable, under the laws
of its jurisdiction of organization and is duly qualified to do business and in good standing as a foreign business entity in
each jurisdiction in which its ownership or lease of property or the conduct of its businesses requires such qualification, except
where the failure to be so qualified or in good standing would not, in the aggregate, reasonably be expected to have a Material
Adverse Effect. Each of the Issuers and the General Partner have all limited partnership, corporate or limited liability company,
as applicable, power and authority necessary to own or hold its properties and to conduct the businesses in which it is engaged
in all material respects. The Issuers and the General Partner do not own or control, directly or indirectly, any equity or long-term
debt securities of any corporation, partnership, limited liability company, joint venture, association or other entity other than
the subsidiaries listed on Schedule 3 to this Agreement.

 

(g)         
The Guarantors. The Guarantors have been duly incorporated or formed and are validly existing as a limited partnership
or limited liability company, as the case may be, in good standing under the laws of the jurisdiction in which they are chartered
or organized, and are duly qualified to do business as a limited partnership or limited liability company, as the case may be,
and are in good standing under the laws of each jurisdiction which requires such qualification, except where the failure to be
so qualified would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Each of the
Guarantors have all limited partnership or limited liability company, as applicable, power and authority necessary to own or hold
its properties and to conduct the businesses in which it is engaged in all material respects.

 

(h)         
General Partner Authority. The General Partner has all limited liability company power and authority to act as the
general partner of the Partnership as described in the Time of Sale Information and the Offering Memorandum.

 

(i)           
Capitalization. As of March 31, 2020, the Partnership had the capitalization as set forth in each of the Time of
Sale Information and the Offering Memorandum under the heading “Capitalization”; and all the outstanding shares of
capital stock or other equity interests of each subsidiary of the Partnership have been duly and validly authorized and issued,
are fully paid and non-assessable and are owned directly or indirectly by the Partnership, free and clear of any lien, charge,
encumbrance, security interest, restriction on voting or transfer or any other claim of any third party (collectively, “Liens”),
except for Liens pursuant to the Credit Agreement.

 

    7

     

    

 

(j)           
 Due Authorization. The Partnership and each of the Guarantors have full right, power and authority to execute and
deliver this Agreement, the Securities and the Indenture (including each Guarantee set forth therein) (collectively, the “Transaction
Documents”), and to perform their respective obligations hereunder and thereunder, as applicable; and all action required
to be taken by the Issuers, the General Partner and the Guarantors for the due and proper authorization, execution and delivery
of each of the Transaction Documents (to the extent party thereto) and the consummation of the Transactions has been duly and
validly taken.

 

(k)         
The Indenture. The Indenture has been duly authorized, executed and delivered by the Issuers and each of the Guarantors
and constitutes a valid and legally binding agreement of the Issuers and each of the Guarantors enforceable against the Issuers
and each of the Guarantors in accordance with its terms, except as enforceability may be limited by (A) applicable bankruptcy,
insolvency, or similar laws (whether considered in a proceeding at law or in equity) affecting the enforcement of creditors’
rights generally or by equitable principles relating to enforceability and (B) by public policy and an implied covenant of good
faith and fair dealing (collectively, the “Enforceability Exceptions”); and the Indenture conforms in all material
respects to the requirements of the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”), and
the rules and regulations of the Commission applicable to an indenture that is qualified thereunder.

 

(l)           
The Securities and the Guarantees. The Securities have been duly authorized by the Issuers and, when duly executed,
authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be duly and validly issued
and outstanding and will constitute valid and legally binding obligations of the Issuers enforceable against the Issuers in accordance
with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture; and the Guarantees
have been duly authorized by each of the Guarantors and, when the Securities have been duly executed, authenticated, issued and
delivered as provided in the Indenture and paid for as provided herein, the Guarantees will be valid and legally binding obligations
of each of the Guarantors, enforceable against each of the Guarantors in accordance with their terms, subject to the Enforceability
Exceptions, and will be entitled to the benefits of the Indenture.

 

(m)       
The Purchase Agreement.  This Agreement has been duly authorized, executed and delivered by the Issuers, the General
Partner and each of the Guarantors.

 

(n)         
Descriptions of the Transaction Documents. Each Transaction Document conforms in all material respects to the description
thereof contained in each of the Time of Sale Information and the Offering Memorandum.

 

    8

     

    

 

(o)         
No Violation or Default. None of the Partnership Entities are (i) in violation of their charter or by-laws
or similar organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both,
would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture,
mortgage, deed of trust, loan agreement or other agreement or instrument to which any of the Partnership Entities are a party
or by which any of the Partnership Entities are bound or to which any property, right or asset of any of the Partnership Entities
is subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator
or governmental or regulatory authority, except, in the case of clauses (ii) and (iii) above, for any such default or violation
that would not, individually or in the aggregate, have a Material Adverse Effect.

 

(p)         
Non-Violation of Existing Instruments. The execution, delivery and performance by the Issuers and each of the Guarantors
of each of the Transaction Documents to which each is a party, the issuance and sale of the Securities and the issuance of the
Guarantees and compliance by the Issuers and each of the Guarantors with the terms thereof and the consummation of the Transactions
did not and will not, as applicable, (i) conflict with or result in a breach or violation of any of the terms or provisions of,
impose any Lien upon any property or assets of any of the Partnership Entities, or constitute a default under, any indenture,
mortgage, deed of trust, loan agreement, license, lease or other agreement or instrument to which any of the Partnership Entities
is a party or by which any of the Partnership Entities is bound or to which any of the property or assets of any of the Partnership
Entities is subject; (ii) result in any violation of the provisions of the organizational documents of any of the Partnership
Entities (collectively, the “Organizational Documents”); or (iii) result in any violation of any statute or
any judgment, order, decree, rule or regulation of any court or governmental agency or body having jurisdiction over the Partnership
Entities or any of their respective properties or assets in a proceeding to which any of them is a party or their respective properties
or assets are bound, except, with respect to clauses (i) and (iii), conflicts or violations that would not reasonably be expected
to have a Material Adverse Effect.

 

(q)         
No Consents, Authorizations or Approvals. No consent, approval, authorization or order of, or filing, registration
or qualification with, any court or governmental agency or body having jurisdiction over the Issuers, the Guarantors, or any of
their respective properties or assets is required for (i) the issuance and sale of the Securities and the issuance of the Guarantees
and compliance by the Issuers and each of the Guarantors with the terms thereof or (ii) the execution, delivery and performance
of the Transaction Documents or the consummation of the Transactions contemplated hereby and thereby, except (A) for the issuance
and sale of the Securities and such consents, approvals, authorizations, orders, filings, registrations or qualifications as may
be required under applicable securities laws of any U.S. state, (B) for such consents, approvals, authorizations, orders, filings,
registrations or qualifications that have been obtained or made, (C) for any such consents, approvals, authorizations, orders,
filings, registrations or qualifications the absence or omission of which would not reasonably be expected to materially impair
the ability of any of the Issuers or the Guarantors to consummate the Transactions provided for in this Agreement and (D) as described
in the Time of Sale Information and the Offering Memorandum.

  

    9

     

    

 

(r)          
 Governmental Proceedings. Except as described in each of the Time of Sale Information and the Offering Memorandum,
there are no legal or governmental proceedings pending to which any of the Partnership Entities is a party or of which any property
or assets of the Partnership Entities is subject that could, in the aggregate, reasonably be expected to have a Material Adverse
Effect or could, in the aggregate, reasonably be expected to have a material adverse effect on the performance of this Agreement
or the consummation of the Transactions contemplated hereby or thereby; and to the Issuers’ and each Guarantor’s knowledge,
no such proceedings are threatened by governmental authorities or others.

 

(s)         
Independent Accountants. During the three years ended December 31, 2018 and the three months ended March 31, 2019,
KPMG LLP, who has certified certain audited consolidated financial statements of the Partnership and Wilmington Holdings, which
are included and incorporated by reference in the Time of Sale Information and the Offering Memorandum, were independent public
accountants with respect to the Partnership and Wilmington Holdings within the applicable rules and regulations adopted by the
Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act. Ernst &
Young LLP, who has certified certain audited consolidated financial statements of the Partnership, which are included and incorporated
by reference in the Time of Sale Information and the Offering Memorandum, are independent public accountants with respect to the
Partnership Entities within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight
Board (United States) and as required by the Securities Act.

 

(t)          
Title to Properties. The Partnership Entities have good and marketable title in fee simple to all real property
and good and marketable title to all personal property owned by them, in each case free and clear of all Liens, except such Liens
(i) as are described in the Time of Sale Information and the Offering Memorandum, (ii) as are permitted by the Credit Agreement,
or (iii) that do not materially affect the value of such property and do not materially interfere with the use made and proposed
to be made of such property by the Partnership Entities as described in the Time of Sale Information and the Offering Memorandum.
All assets held under lease by the Partnership Entities are held by them under valid, subsisting and enforceable leases, with
such exceptions as do not materially interfere with the use made and proposed to be made of such assets by the Partnership Entities
as described in the Time of Sale Information and the Offering Memorandum.

 

(u)         
Intellectual Property. The Partnership Entities own or possess adequate rights to use all material patents, patent
applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses,
know-how, software, systems and technology (including trade secrets and other unpatented and/or unpatentable proprietary or confidential
information, systems or procedures) necessary for the conduct of their respective businesses and have no reason to believe that
the conduct of their respective businesses will conflict with, and have not received any notice of any claim of conflict with,
any such rights of others, in each case, except as would not reasonably be expected to have a Material Adverse Effect.

 

    10

     

    

 

(v)         
Related-Party Transactions. No relationship, direct or indirect, exists between or among the Partnership Entities,
on the one hand, and the directors, officers, unitholders, customers or suppliers of the Partnership Entities or the General Partner,
on the other hand, that is required to be described in the Time of Sale Information and the Offering Memorandum which is not so
described.

 

(w)        
Investment Company Act. The Issuers and the Guarantors are not and, after giving effect to the offer and sale of
the Securities by the Issuers and the application of the proceeds therefrom as described under “Use of proceeds” in
the Time of Sale Information and the Offering Memorandum, the Issuer and the Guarantors will not be, an “investment company”
within the meaning of the Investment Company Act of 1940, as amended (the “Investment Company Act”).

 

(x)         
Tax Law Compliance. Except as would not individually or in the aggregate result in a Material Adverse Effect, (i)
the Partnership Entities have filed all federal, state, local and foreign tax returns required to be filed through the date hereof,
subject to permitted extensions, and have paid all taxes due, (ii) no tax deficiency has been determined adversely to the Partnership
Entities and (iii) to the knowledge of the Issuers and the Guarantors there are no tax deficiencies that have been, or could reasonably
be expected to be, asserted against any of the Partnership Entities.

 

(y)         
All Necessary Permits. The Partnership Entities have such permits, licenses, patents, franchises, certificates of
need and other approvals or authorizations of governmental or regulatory authorities (“Permits”) as are necessary
under applicable law to own their properties and conduct their businesses in the manner described in the Time of Sale Information
and the Offering Memorandum, except for any of the foregoing that would not, in the aggregate, reasonably be expected to have
a Material Adverse Effect or except as described in the Time of Sale Information and the Offering Memorandum. The Partnership
Entities have fulfilled and performed all of their obligations with respect to the Permits, and no event has occurred that allows,
or after notice or lapse of time would allow, revocation or termination thereof or results in any other impairment of the rights
of the holder of any such Permits, except for any of the foregoing that would not reasonably be expected to have a Material Adverse
Effect or except as described in the Time of Sale Information and the Offering Memorandum. None of the Partnership Entities have
received notice of any revocation or modification of any such Permits or have any reason to believe that any such Permits will
not be renewed in the ordinary course, except those that would not reasonably be expected to have a Material Adverse Effect.

 

(z)         
No Labor Disputes. No labor disturbance by or dispute with the employees of the Partnership Entities exists or,
to the knowledge of the Issuers and each Guarantor, is imminent that could reasonably be expected to have a Material Adverse Effect.

 

    11

     

    

 

(aa)      
 Compliance with and Liability under Environmental Laws. Except as described in the Time of Sale Information and
the Offering Memorandum, the Partnership Entities (i) are, and at all times prior hereto were, in compliance with all laws, regulations,
ordinances, rules, orders, judgments, decrees, permits or other legal requirements of any governmental authority, including without
limitation any international, foreign, national, state, provincial, regional, or local authority, relating to pollution, the protection
of human health or safety, the environment, or natural resources, or the use, handling, storage, manufacturing, transportation,
treatment, discharge, disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants (“Environmental
Laws”) applicable to such entity, which compliance includes, without limitation, obtaining, maintaining and complying
with all permits and authorizations and approvals required by Environmental Laws to conduct their respective businesses, and (ii)
have not received notice or otherwise have knowledge of any actual or alleged violation of Environmental Laws, or of any actual
or potential liability for or other obligation concerning the presence, disposal or release of hazardous or toxic substances or
wastes, pollutants or contaminants, except in the case of clause (i) or (ii) where such non-compliance, failure to receive the
required permits or failure to comply with the terms and conditions of such permits, violation, liability, or other obligation
would not, in the aggregate, reasonably be expected to have a Material Adverse Effect. Except as described in the Time of Sale
Information and the Offering Memorandum, (x) there are no proceedings that are pending, or known to be contemplated, against the
Partnership Entities under Environmental Laws in which a governmental authority is also a party, other than such proceedings regarding
which it is reasonably believed no monetary sanctions of $100,000 or more will be imposed, (y) the Issuers and each Guarantor
are not aware of any issues regarding compliance with Environmental Laws, including any pending or proposed Environmental Laws,
or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants
or contaminants, that could reasonably be expected to have a Material Adverse Effect, and (z) none of the Partnership Entities
anticipate material capital expenditures relating to Environmental Laws.

 

(bb)      
ERISA Compliance. (i) Each “employee benefit plan” (within the meaning of Section 3(3) of the Employee
Retirement Income Security Act of 1974, as amended (“ERISA”)) for which the Partnership or any member of its
 “Controlled Group” (defined as any organization which is a member of a controlled group of corporations within the
meaning of Section 414 of the Internal Revenue Code of 1986, as amended (the “Code”)) would have any liability
(each a “Plan”) has been maintained in compliance with its terms and with the requirements of all applicable
statutes, rules and regulations including ERISA and the Code; (ii) no prohibited transaction, within the meaning of Section 406
of ERISA or Section 4975 of the Code, has occurred with respect to any Plan excluding transactions effected pursuant to a statutory
or administrative exemption; (iii) with respect to each Plan subject to Title IV of ERISA (A) no “reportable event”
(within the meaning of Section 4043(c) of ERISA) has occurred or is reasonably expected to occur, (B) no “accumulated funding
deficiency” (within the meaning of Section 302 of ERISA or Section 412 of the Code), whether or not waived, has occurred
or is reasonably expected to occur, (C) the fair market value of the assets under each Plan exceeds the present value of all benefits
accrued under such Plan (determined based on those assumptions used to fund such Plan), and (D) neither the Partnership nor any
member of its Controlled Group has incurred, or reasonably expects to incur, any liability under Title IV of ERISA (other than
contributions to the Plan or premiums to the Pension Benefit Guaranty Corporation in the ordinary course and without default)
in respect of a Plan (including a “multiemployer plan”, within the meaning of Section 4001(c)(3) of ERISA); and (iv)
each Plan that is intended to be qualified under Section 401(a) of the Code is so qualified and nothing has occurred, whether
by action or by failure to act, which would cause the loss of such qualification.

 

    12

     

    

 

(cc)      
Disclosure Controls. (i) The Partnership Entities maintain disclosure controls and procedures (as such term is defined
in Rule 13a-15(e) under the Exchange Act), (ii) such disclosure controls and procedures are designed to ensure that the information
is accumulated and communicated to management of the General Partner, including the principal executive officer and principal
financial officer of the General Partner, as appropriate, and (iii) to the extent required by Rule 13a-15 of the Exchange Act,
such disclosure controls and procedures are effective in all material respects to perform the functions for which they were established.

 

(dd)      
Internal Controls. The Partnership Entities maintain systems of “internal control over financial reporting”
(as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed
by, or under the supervision of, their respective principal executive and principal financial officers, or persons performing
similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with GAAP. The Partnership Entities maintain internal accounting controls sufficient
to provide reasonable assurances regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient to provide
reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorization,
(ii) transactions are recorded as necessary to permit preparation of the Partnership’s financial statements in conformity
with GAAP and to maintain accountability for its assets, (iii) access to the Partnership’s assets is permitted only in accordance
with management’s general or specific authorization, and (iv) the recorded accountability for the Partnership’s assets
is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences. As of
the date of the most recent balance sheet of the Partnership and its consolidated subsidiaries reviewed or audited by Ernst &
Young LLP, there were no material weaknesses in the Partnership Entities’ internal controls.

 

(ee)      
No Significant Deficiencies. Since the date of the most recent balance sheet of the Partnership reviewed or audited
by Ernst & Young, LLP, (i) the Partnership Entities have not been advised of or become aware of (A) any significant deficiencies
or any material weaknesses in the design or operation of internal controls that are reasonably likely to adversely affect the
ability of the Partnership Entities to record, process, summarize and report financial data, or (B) any fraud, whether or not
material, that involves management or other employees who have a significant role in the internal controls of the Partnership
Entities; and (ii) there have been no significant changes in internal controls or in other factors that are reasonably likely
to materially affect internal controls, including any corrective actions with regard to significant deficiencies and material
weaknesses.

 

    13

     

    

 

(ff)         
Insurance. The Partnership Entities carry, or are covered by, insurance from reputable insurers in such amounts
and covering such risks as is reasonably adequate for the conduct of their respective businesses and the value of their respective
properties and as is customary for companies engaged in similar businesses in similar industries. All policies of insurance of
the Partnership Entities are in full force and effect; the Partnership Entities are in compliance with the terms of such policies
in all material respects; and none of the Partnership Entities have received notice from any insurer or agent of such insurer
that capital improvements or other expenditures are required or necessary to be made in order to continue such insurance; there
are no material claims by the Partnership Entities under any such policy or instrument as to which any insurance company is denying
liability or defending under a reservation of rights clause; and the Partnership Entities have no reason to believe that they
will not be able to renew their existing insurance coverage as and when such coverage expires or to obtain similar coverage from
similar insurers as may be necessary to continue their business at a cost that would not reasonably be expected to have a Material
Adverse Effect.

 

(gg)      
Cybersecurity; Data Protection. The Partnership Entities’ information technology assets and equipment, computers,
systems, networks, hardware, software, websites, applications, and databases (collectively, “IT Systems”) are
adequate for, and operate and perform as necessary for the operation of the business of the Partnership Entities as currently
conducted, except as would not, individually or in the aggregate, have a Material Adverse Effect. The Partnership Entities conduct
industry-standard scans of its IT Systems to detect and address material bugs, errors, defects, Trojan horses, time bombs, malware
and other corruptants. The Partnership Entities have implemented and maintained commercially reasonable controls, policies, procedures,
and safeguards to maintain and protect their material confidential information and the integrity and security of all IT Systems
and sensitive data (including all personal, personally identifiable, confidential or regulated data (“Sensitive Data”))
used in connection with their businesses, and there have been no known breaches, violations, outages or unauthorized uses of or
accesses to same, except as would not, individually or in the aggregate, have a Material Adverse Effect, and the Partnership Entities
have not had a duty to notify any other person, nor any incidents under internal review or investigations relating to the same.
The Partnership Entities are presently in material compliance with all applicable laws or statutes and all judgments, orders,
and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
applicable to the privacy and security of its IT Systems and Sensitive Data and to the protection of such IT Systems and Sensitive
Data from unauthorized use, access, misappropriation or modification.

 

    14

     

    

 

(hh)              
No Unlawful Contributions or Other Payments. None of the Partnership Entities, nor, to the knowledge of the Issuers
and each of the Guarantors, any director, officer, agent, employee or other person associated with or acting on behalf of any
of the Partnership Entities, has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful
expense relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government
official or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices
Act of 1977, as amended, or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign
Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom,
or any other applicable anti-bribery or anti-corruption law; or (iv) made any bribe, rebate, payoff, influence payment, kickback
or other unlawful payment. The Partnership Entities have instituted, maintain and enforce, policies and procedures designed to
promote and ensure compliance with all applicable anti-bribery and anti-corruption laws.

 

(ii)                 
No Conflict with Money Laundering Laws. The operations of the Partnership Entities are and have been conducted at
all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and
Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where any
of the Partnership Entities conduct business, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”)
and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving
the Partnership Entities with respect to the Money Laundering Laws is pending or, to the knowledge of the Issuers and each of
the Guarantors, threatened.

 

(jj)                 
No Conflict with Sanctions Laws. None of the Partnership Entities, their directors, officers, or agents, nor, to
the knowledge of the Issuers and each of the Guarantors, any agent or affiliate of the Partnership Entities is currently the subject
of any U.S. sanctions regulations administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)
or the U.S. Department of State, the United Nations Security Council (“UNSC”), the European Union, Her Majesty’s
Treasury (“HMT”), or other relevant sanctions authority (collectively, “Sanctions”), including,
without limitation, designation on OFAC’s Specially Designated Nationals and Blocked Person List (an “SDN”)
or any person majority owned by an SDN, or where relevant under applicable Sanctions, controlled by a Sanctions target, nor are
any of the Partnership Entities located, organized or resident in a country or territory that is the subject or target of Sanctions,
including, without limitation, Cuba, Iran, North Korea, Syria, and the Crimea region of Ukraine (each, a “Sanctioned
Country”); and the Partnership will not directly or indirectly use the proceeds of the offering, or lend, contribute
or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate
any activities of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions,
(ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result
in a violation by any person (including any person participating in the transaction, whether as underwriter, initial purchaser,
advisor, investor or otherwise) of Sanctions. For the past five years, the Partnership Entities have not knowingly engaged in,
and are not now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction
is or was the subject or the target of Sanctions or with any Sanctioned Country.

 

    15

     

    

 

(kk)              
Solvency. On and immediately after the Closing Date, the Issuers and each Guarantor (after giving effect to the
issuance and sale of the Securities, the issuance of the Guarantees and the other transactions related thereto as described in
each of the Time of Sale Information and the Offering Memorandum) will be Solvent. As used in this paragraph, the term “Solvent”
means, with respect to a particular date and entity, that on such date (i) the fair value (and present fair saleable value) of
the assets of such entity is not less than the total amount required to pay the probable liability of such entity on its total
existing debts and liabilities (including contingent liabilities) as they become absolute and matured; (ii) such entity is able
to realize upon its assets and pay its debts and other liabilities, contingent obligations and commitments as they mature and
become due in the normal course of business; (iii) assuming consummation of the issuance and sale of the Securities and the issuance
of the Guarantees as contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum, such entity does
not have, intend to incur or believe that it will incur debts or liabilities beyond its ability to pay as such debts and liabilities
mature; (iv) such entity is not engaged in any business or transaction, and does not propose to engage in any business or transaction,
for which its property would constitute unreasonably small capital; and (v) such entity is not a defendant in any civil action
that would result in a judgment that such entity is or would become unable to satisfy.

 

(ll)                 
No Restrictions on Subsidiaries. No subsidiary of the Partnership is prohibited, directly or indirectly, under any
agreement or other instrument to which it is a party or subject, from paying any dividends to the Partnership, from making any
other distribution on such subsidiary’s capital stock or similar ownership interest, from repaying to the Partnership any
loans or advances to such subsidiary from the Partnership, or from transferring any of such subsidiary’s properties or assets
to the Partnership or any other Partnership Entity upon consummation of the Transactions on the Closing Date as described in each
of the Time of Sale Information and the Offering Memorandum, except, in each case, for such restrictions contained in (i) the
Credit Agreement, (ii) the Fourth Amended and Restated Limited Liability Company Agreement of Enviva Wilmington Holdings, LLC
dated December 29, 2016, as amended, (iii) the Second Amended and Restated Credit Agreement by and between Enviva Wilmington Holdings,
LLC and Enviva, LP, dated April 2, 2019, or (iv) or that are permitted by the Indenture.

 

(mm)           
Brokers. None of the Partnership Entities are a party to any contract, agreement or understanding with any person
(other than this Agreement) that would give rise to a valid claim against any of them or the Initial Purchasers for a brokerage
commission, finder’s fee or like payment in connection with the offering and sale of the Securities.

 

    16

     

    

 

(nn)              
Rule 144A Eligibility. On the Closing Date, the Securities will not be of the same class as securities listed on
a national securities exchange registered under Section 6 of the Exchange Act or quoted in an automated inter-dealer quotation
system; and each of the Preliminary Offering Memorandum and the Offering Memorandum, as of its respective date, contains or will
contain all the information that, if requested by a prospective purchaser of the Securities, would be required to be provided
to such prospective purchaser pursuant to Rule 144A(d)(4) under the Securities Act.

 

(oo)              
No Integration. Neither the Partnership nor any of its affiliates (as defined in Rule 501(b) of Regulation D) has,
directly or through any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security
(as defined in the Securities Act), that is or will be integrated with the sale of the Securities in a manner that would require
registration of the Securities under the Securities Act.

 

(pp)              
No General Solicitation or Directed Selling Efforts. None of the Partnership nor any of its affiliates or any other
person acting on its or their behalf (other than the Initial Purchasers, as to which no representation is made) has (i) solicited
offers for, or offered or sold, the Securities by means of any form of general solicitation or general advertising within the
meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the
Securities Act or (ii) engaged in any directed selling efforts within the meaning of Regulation S under the Securities Act (“Regulation
S”), and all such persons have complied with the offering restrictions requirement of Regulation S.

 

(qq)              
Securities Law Exemptions. Assuming the accuracy of the representations and warranties of the Initial Purchasers
contained in Section 2(b) (including Annex C hereto) and their compliance with their agreements set forth therein, it is not necessary,
in connection with the issuance and sale of the Securities to the Initial Purchasers and the offer, resale and delivery of the
Securities by the Initial Purchasers in the manner contemplated by this Agreement, the Time of Sale Information and the Offering
Memorandum, to register the Securities under the Securities Act or to qualify the Indenture under the Trust Indenture Act.

 

(rr)                
No Price Stabilization or Manipulation. The Issuers and each Guarantor have not (i) taken, directly or indirectly,
any action designed to or that has constituted or that could reasonably be expected to cause or result in, under the Exchange
Act or otherwise, stabilization or manipulation of the price of any security of the Issuers and the Guarantors or (ii) sold, bid
for, purchased or paid any person (other than as contemplated by this Agreement) any compensation for soliciting purchases of
the Securities.

 

(ss)              
Margin Rules. Neither the issuance, sale and delivery of the Securities nor the application of the proceeds thereof
by the Issuers as described in each of the Time of Sale Information and the Offering Memorandum will violate Regulation T, U or
X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.

 

    17

     

    

 

(tt)                 
Forward-Looking Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act
and Section 21E of the Exchange Act) included or incorporated by reference in any of the Time of Sale Information or the Offering
Memorandum has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.

 

(uu)              
Market Data. The statistical and market-related data included or incorporated by reference in the Time of Sale Information
and the Offering Memorandum are based on or derived from sources that the Issuers believe to be reliable in all material respects.

 

(vv)              
Sarbanes-Oxley Compliance. There is not and has not been any failure on the part of the Partnership or any of the
directors or officers of the General Partner, in their capacities as such, to comply with any provision of the Sarbanes-Oxley
Act of 2002 and the rules and regulations promulgated in connection therewith, in each case, that are effective and applicable
to the Partnership.

 

4.       Further
Agreements of the Issuers and the Guarantors. The Issuers and the Guarantors jointly and severally covenant and agree with
each Initial Purchaser that:

 

(a)         
Delivery of Copies. The Issuers will deliver, without charge, to the Initial Purchasers as many copies of the Preliminary
Offering Memorandum, any other Time of Sale Information, any Issuer Written Communication and the Offering Memorandum (including
all amendments and supplements thereto) as the Representative may reasonably request.

 

(b)         
Offering Memorandum, Amendments or Supplements. Before finalizing the Offering Memorandum or making or distributing
any amendment or supplement to any of the Time of Sale Information or the Offering Memorandum or filing with the Commission any
document that will be incorporated by reference therein, the Issuers will furnish to the Representative and counsel for the Initial
Purchasers a copy of the proposed Offering Memorandum or such amendment or supplement or document to be incorporated by reference
therein for review, and will not distribute any such proposed Offering Memorandum, amendment or supplement or file any such document
with the Commission to which the Representative reasonably objects.

 

(c)         
Additional Written Communications. Before making, preparing, using, authorizing, approving or referring to any Issuer
Written Communication, the Issuers and the Guarantors will furnish to the Representative and counsel for the Initial Purchasers
a copy of such written communication for review and will not make, prepare, use, authorize, approve or refer to any such written
communication to which the Representative reasonably objects.

 

    18

     

    

 

(d)         
 Notice to the Representative. The Issuers will advise the Representative promptly, and confirm such advice in writing,
(i) of the issuance by any governmental or regulatory authority of any order preventing or suspending the use of any of the Time
of Sale Information, any Issuer Written Communication or the Offering Memorandum or the initiation or threatening of any proceeding
for that purpose; (ii) of the occurrence of any event at any time prior to the completion of the initial offering of the Securities
as a result of which any of the Time of Sale Information, any Issuer Written Communication or the Offering Memorandum as then
amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances existing when such Time of Sale Information, Issuer Written
Communication or the Offering Memorandum is delivered to a purchaser, not misleading; and (iii) of the receipt by the Issuers
of any notice with respect to any suspension of the qualification of the Securities for offer and sale in any jurisdiction or
the initiation or threatening of any proceeding for such purpose; and the Issuers will use their reasonable best efforts to prevent
the issuance of any such order preventing or suspending the use of any of the Time of Sale Information, any Issuer Written Communication
or the Offering Memorandum or suspending any such qualification of the Securities and, if any such order is issued, will obtain
as soon as possible the withdrawal thereof.

 

(e)         
Time of Sale Information. If at any time prior to the Closing Date (i) any event shall occur or condition shall
exist as a result of which any of the Time of Sale Information as then amended or supplemented would include any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading or (ii) it is necessary to amend or supplement the Time of Sale Information to comply
with law, the Issuers will immediately notify the Initial Purchasers thereof and forthwith prepare and, subject to paragraph (b)
above, furnish to the Initial Purchasers such amendments or supplements to the Time of Sale Information (or any document to be
filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in any of the Time
of Sale Information as so amended or supplemented (including such documents to be incorporated by reference therein) will not,
in the light of the circumstances under which they were made, be misleading or so that any of the Time of Sale Information will
comply with law.

 

(f)          
Ongoing Compliance of the Offering Memorandum. If at any time prior to the completion of the initial offering of
the Securities (i) any event shall occur or condition shall exist as a result of which the Offering Memorandum as then amended
or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements therein, in the light of the circumstances existing when the Offering Memorandum is delivered to a purchaser,
not misleading or (ii) it is necessary to amend or supplement the Offering Memorandum to comply with law, the Issuers will immediately
notify the Initial Purchasers thereof and forthwith prepare and, subject to paragraph (b) above, furnish to the Initial Purchasers
such amendments or supplements to the Offering Memorandum (or any document to be filed with the Commission and incorporated by
reference therein) as may be necessary so that the statements in the Offering Memorandum as so amended or supplemented (including
such document to be incorporated by reference therein) will not, in the light of the circumstances existing when the Offering
Memorandum is delivered to a purchaser, be misleading or so that the Offering Memorandum will comply with law.

 

    19

     

    

 

(g)         
Blue Sky Compliance. The Issuers will qualify the Securities for offer and sale under the securities or Blue Sky
laws of such jurisdictions as the Representative shall reasonably request and will continue such qualifications in effect so long
as required for the offering and resale of the Securities; provided that neither the Issuers nor any of the Guarantors
shall be required to (i) qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction
where it would not otherwise be required to so qualify, (ii) file any general consent to service of process in any such jurisdiction
or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.

 

(h)         
Clear Market. During the period from the date hereof through and including the date that is 90 days after the date
hereof, the Issuers and each of the Guarantors will not, without the prior written consent of the Representative, offer, sell,
contract to sell or otherwise dispose of any debt securities issued or guaranteed by the Issuers or any of the Guarantors and
having a tenor of more than one year.

 

(i)           
Use of Proceeds. The Issuers will apply the net proceeds from the sale of the Securities as described in each of
the Time of Sale Information and the Offering Memorandum under the heading “Use of proceeds.”

 

(j)           
Supplying Information. While the Securities remain outstanding and are “restricted securities” within
the meaning of Rule 144(a)(3) under the Securities Act, the Issuers and each of the Guarantors will, during any period in which
the Partnership is not subject to and in compliance with Section 13 or 15(d) of the Exchange Act, furnish to holders of the Securities
and prospective purchasers of the Securities designated by such holders, upon the request of such holders or such prospective
purchasers, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act.

 

(k)         
DTC. The Issuers will assist the Initial Purchasers in arranging for the Securities to be eligible for clearance
and settlement through DTC.

 

(l)           
No Resales by the Issuers. The Issuers will not, and will not permit any of their affiliates (as defined in Rule 144
under the Securities Act) to, resell any of the Securities that have been acquired by any of them, except for Securities purchased
by the Issuers or any of their affiliates and resold in a transaction registered under the Securities Act.

 

(m)       
No Integration. Neither the Issuers nor any of their affiliates (as defined in Rule 501(b) of Regulation D) will,
directly or through any agent, sell, offer for sale, solicit offers to buy or otherwise negotiate in respect of, any security
(as defined in the Securities Act), that is or will be integrated with the sale of the Securities in a manner that would require
registration of the Securities under the Securities Act.

 

    20

     

    

 

 

(n)         
No General Solicitation or Directed Selling Efforts. None of the Issuers or any of their affiliates or any other
person acting on its or their behalf (other than the Initial Purchasers, as to which no covenant is given) will (i) solicit offers
for, or offer or sell, the Securities by means of any form of general solicitation or general advertising within the meaning of
Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities
Act or (ii) engage in any directed selling efforts within the meaning of Regulation S, and all such persons will comply with the
offering restrictions requirement of Regulation S.

 

(o)         
No Stabilization. Neither the General Partner, the Issuers nor any of the Guarantors will take, directly or indirectly,
any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price
of the Securities.

 

5.      Certain
Agreements of the Initial Purchasers.Each Initial Purchaser hereby represents and agrees that it has not and will not
use, authorize use of, refer to, or participate in the planning for use of, any written communication that constitutes an offer
to sell or the solicitation of an offer to buy the Securities other than (i) the Preliminary Offering Memorandum and the Offering
Memorandum, (ii) any written communication that contains either (a) no “issuer information” (as defined in Rule 433(h)(2)
under the Securities Act) or (b) “issuer information” that was included (including through incorporation by reference)
in the Time of Sale Information or the Offering Memorandum, (iii) any written communication listed on Annex A or prepared pursuant
to Section 4(c) (including any electronic road show) above, (iv) any written communication prepared by such Initial Purchaser
and approved by the Partnership and the Representative in advance in writing or (v) any written communication relating to or that
contains the terms of the Securities and/or other information that was included (including through incorporation by reference)
in the Time of Sale Information or the Offering Memorandum.

 

6.       Conditions
of Initial Purchasers’ Obligations. The obligation of each Initial Purchaser to purchase Securities on the Closing Date
as provided herein is subject to the performance by the Issuers and each of the Guarantors of their respective covenants and other
obligations hereunder and to the following additional conditions:

 

(a)         
Representations and Warranties. The representations and warranties of the Issuers and the Guarantors contained herein
shall be true and correct on the date hereof and on and as of the Closing Date; and the statements of the Issuers, the Guarantors
and their respective officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as
of the Closing Date.

 

(b)         
No Downgrade. Subsequent to the earlier of (A) the Time of Sale and (B) the execution and delivery of this Agreement,
(i) no downgrading shall have occurred in the rating accorded the Securities or any other debt securities or preferred stock issued
or guaranteed by any of the Partnership Entities by either S&P Global Ratings, Moody’s Investors Service, Inc. or Fitch
Ratings Inc. and (ii) no such organization shall have publicly announced that it has under surveillance or review, or has changed
its outlook with respect to, its rating of the Securities or of any other debt securities or preferred stock issued or guaranteed
by any of the Partnership Entities (other than an announcement with positive implications of a possible upgrading).

 

    21

     

    

 

(c)         
No Material Adverse Change. No event or condition of a type described in Section 3(e) hereof shall have occurred
or shall exist, which event or condition is not described in each of the Time of Sale Information (excluding any amendment or
supplement thereto) and the Offering Memorandum (excluding any amendment or supplement thereto) the effect of which in the judgment
of the Representative makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on
the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum.

 

(d)         
Officer’s Certificate. The Representative shall have received on and as of the Closing Date a certificate
of an executive officer of the Issuers and of each Guarantor who has specific knowledge of the Issuers’ or such Guarantor’s
financial matters and is satisfactory to the Representative (i) confirming that such officer has carefully reviewed the Time of
Sale Information and the Offering Memorandum and, to the knowledge of such officer, the representations set forth in Sections
3(a) and 3(b) hereof are true and correct, (ii) confirming that the other representations and warranties of the Issuers and the
Guarantors in this Agreement are true and correct and that the Issuers and the Guarantors have complied with all agreements and
satisfied all conditions on their part to be performed or satisfied hereunder at or prior to the Closing Date and (iii) to the
effect set forth in paragraphs (b) and (c) above.

 

(e)         
Comfort Letters.

 

i.     
On the date of this Agreement and on the Closing Date, KPMG LLP shall have furnished to the Representative, at the request
of the Partnership, letters, dated the respective dates of delivery thereof and addressed to the Initial Purchasers, in form and
substance reasonably satisfactory to the Representative, containing statements and information of the type customarily included
in accountants’ “comfort letters” to underwriters with respect to the pro forma financial statements, certain
financial statements and certain financial information contained or incorporated by reference in each of the Time of Sale Information
and the Offering Memorandum.

 

ii.   
On the date of this Agreement and on the Closing Date, Ernst & Young LLP shall have furnished to the Representative,
at the request of the Partnership, letters, dated the respective dates of delivery thereof and addressed to the Initial Purchasers,
in form and substance reasonably satisfactory to the Representative, containing statements and information of the type customarily
included in accountants’ “comfort letters” to underwriters with respect to certain financial statements and
certain financial information contained or incorporated by reference in each of the Time of Sale Information and the Offering
Memorandum; provided that the letter delivered on the Closing Date shall use a “cut-off” date no more than
three business days prior to the Closing Date.

 

    22

     

    

 

iii.  
 On the date of this Agreement and on the Closing Date, the Partnership shall have furnished to the Representative a certificate,
addressed to the Initial Purchasers, of its chief financial officer with respect to certain financial data contained in the Time
of Sale Information and the Offering Memorandum, providing “management comfort” with respect to such information,
in form and substance reasonably satisfactory to the Representative.

 

(f)          
Opinion and 10b-5 Statement of Counsel for the Issuers. Vinson & Elkins L.L.P., counsel for the Issuers and
the Guarantors, shall have furnished to the Representative, at the request of the Issuers, their written opinion and 10b-5 statement,
dated the Closing Date and addressed to the Initial Purchasers, in form and substance reasonably satisfactory to the Representative.

 

(g)         
Opinion and 10b-5 Statement of Counsel for the Initial Purchasers. The Representative shall have received on and
as of the Closing Date an opinion and 10b-5 statement, addressed to the Initial Purchasers, of Latham & Watkins LLP, counsel
for the Initial Purchasers, with respect to such matters as the Representative may reasonably request, and such counsel shall
have received such documents and information as they may reasonably request to enable them to pass upon such matters.

 

(h)         
No Legal Impediment to Issuance. No action shall have been taken and no statute, rule, regulation or order shall
have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the
Closing Date, prevent the issuance or sale of the Securities or the issuance of the Guarantees; and no injunction or order of
any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of
the Securities or the issuance of the Guarantees.

 

(i)           
Good Standing. The Representative shall have received on and as of the Closing Date satisfactory evidence of the
good standing of the Partnership Entities in their respective jurisdictions of organization and their good standing in such other
jurisdictions as the Representative may reasonably request, in each case in writing or any standard form of telecommunication
from the appropriate governmental authorities of such jurisdictions.

 

(j)           
DTC. The Securities shall be eligible for clearance and settlement through DTC.

 

(k)         
Securities. The Securities shall have been duly executed and delivered by a duly authorized officer of each of the
Issuers and duly authenticated by the Trustee.

 

    23

     

    

 

(l)           
 Additional Documents. On or prior to the Closing Date, the Issuers and the Guarantors shall have furnished to the
Representative such further certificates and documents as the Representative may reasonably request.

 

All opinions, letters, certificates
and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only
if they are in form and substance reasonably satisfactory to counsel for the Initial Purchasers.

 

7.       Indemnification
and Contribution.

 

(a)         
Indemnification of the Initial Purchasers. The Issuers and each of the Guarantors jointly and severally agree to
indemnify and hold harmless each Initial Purchaser, its affiliates, directors and officers and each person, if any, who controls
such Initial Purchaser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against
any and all losses, claims, damages and liabilities (including, without limitation, legal fees and other expenses incurred in
connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several,
that arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Preliminary
Offering Memorandum, any of the other Time of Sale Information, any Issuer Written Communication or the Offering Memorandum (or
any amendment or supplement thereto) or any omission or alleged omission to state therein a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading, in each case except
insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged
untrue statement or omission made in reliance upon and in conformity with any information relating to any Initial Purchaser furnished
to the Issuers in writing by such Initial Purchaser through the Representative expressly for use therein.

 

(b)         
Indemnification of the Issuers and the Guarantors. Each Initial Purchaser agrees, severally and not jointly, to
indemnify and hold harmless (i) as of the date hereof, the Issuers and each of the Guarantors (ii) each of the directors and officers
of the Issuers and the Guarantors and (iii) each person, if any, who controls the Issuers or any of the Guarantors within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in
paragraph (a) above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon,
any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information
relating to such Initial Purchaser furnished to the Issuers in writing by such Initial Purchaser through the Representative expressly
for use in the Preliminary Offering Memorandum, any of the other Time of Sale Information, any Issuer Written Communication or
the Offering Memorandum (or any amendment or supplement thereto), it being understood and agreed that the only such information
consists of the following paragraphs in the Preliminary Offering Memorandum and the Offering Memorandum: paragraph six (first,
second, third and fourth sentences only), paragraph ten (fourth sentence only) and paragraph eleven (first sentence only) under
the caption “Plan of distribution.”

 

    24

     

    

 

(c)         
Notice and Procedures. If any suit, action, proceeding (including any governmental
or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification
may be sought pursuant to either paragraph (a) or (b) above, such person (the “Indemnified Person”) shall promptly
notify the person against whom such indemnification may be sought (the “Indemnifying Person”) in writing; provided
that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under paragraph
(a) or (b) above except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or
defenses) by such failure; and provided, further, that the failure to notify the Indemnifying Person shall not relieve
it from any liability that it may have to an Indemnified Person otherwise than under paragraph (a) or (b) above. If any such proceeding
shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying
Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified
Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification
pursuant to this Section 7 that the Indemnifying Person may designate in such proceeding and shall pay the fees and expenses of
such proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding,
any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the
expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to
the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the
Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal defenses available
to it that are different from or in addition to those available to the Indemnifying Person; or (iv) the named parties in any such
proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation
of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is
understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same
jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified
Persons, and that all such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any
Initial Purchaser, its affiliates, directors and officers and any control persons of such Initial Purchaser shall be designated
in writing by Barclays Capital Inc. and any such separate firm for the Issuers, the Guarantors, their respective directors and
officers and any control persons of the Issuers and the Guarantors shall be designated in writing by the Partnership. The Indemnifying
Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such
consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person
from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at
any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for fees and
expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding
effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by the Indemnifying
Person of such request and (ii) the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such
request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person,
effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been
a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x) includes an
unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from
all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission
of fault, culpability or a failure to act by or on behalf of any Indemnified Person.

 

    25

     

    

 

(d)         
Contribution. If the indemnification provided for in paragraph (a) or (b) above is unavailable to an Indemnified
Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person
under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable
by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate
to reflect the relative benefits received by the Issuers and the Guarantors on the one hand and the Initial Purchasers on the
other from the offering of the Securities or (ii) if the allocation provided by clause (i) is not permitted by applicable law,
in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative
fault of the Issuers and the Guarantors on the one hand and the Initial Purchasers on the other in connection with the statements
or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations.
The relative benefits received by the Issuers and the Guarantors on the one hand and the Initial Purchasers on the other shall
be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Issuers from
the sale of the Securities and the total discounts and commissions received by the Initial Purchasers in connection therewith,
as provided in this Agreement, bear to the aggregate offering price of the Securities. The relative fault of the Issuers and the
Guarantors on the one hand and the Initial Purchasers on the other shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates
to information supplied by the Issuers or any Guarantor or by the Initial Purchasers and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission.

 

    26

     

    

 

(e)         
Limitation on Liability. The Issuers, the Guarantors and the Initial Purchasers agree that it would not be just
and equitable if contribution pursuant to this Section 7 were determined by pro rata allocation (even if the Initial Purchasers
were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable
considerations referred to in paragraph (d) above. The amount paid or payable by an Indemnified Person as a result of the losses,
claims, damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the limitations set
forth above, any legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding
the provisions of this Section 7, in no event shall an Initial Purchaser be required to contribute any amount in excess of the
amount by which the total discounts and commissions received by such Initial Purchaser with respect to the offering of the Securities
exceeds the amount of any damages that such Initial Purchaser has otherwise been required to pay by reason of such untrue or alleged
untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.
The Initial Purchasers’ obligations to contribute pursuant to this Section 7 are several in proportion to their respective
purchase obligations hereunder and not joint.

 

(f)          
Non-Exclusive Remedies. The remedies provided for in this Section 7 are not exclusive and shall not limit any rights
or remedies that may otherwise be available to any Indemnified Person at law or in equity.

 

8.       Effectiveness
of Agreement. This Agreement shall become effective as of the date first written above.

 

9.       Termination.
This Agreement may be terminated in the absolute discretion of the Representative, by notice to the Issuers, if after the execution
and delivery of this Agreement and on or prior to the Closing Date (i) trading generally shall have been suspended or materially
limited on the New York Stock Exchange or the over-the-counter market; (ii) trading of any securities issued or guaranteed by
the Issuers or any of the Guarantors shall have been suspended on any exchange or in any over-the-counter market; (iii) a general
moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv) there shall
have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within
or outside the United States, that, in the judgment of the Representative, is material and adverse and makes it impracticable
or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by
this Agreement, the Time of Sale Information and the Offering Memorandum.

 

    27

     

    

 

10.       Defaulting
Initial Purchaser.

 

(a)         
If, on the Closing Date, any Initial Purchaser defaults on its obligation to purchase the Securities that it has agreed
to purchase hereunder, the non-defaulting Initial Purchasers may in their discretion arrange for the purchase of such Securities
by other persons satisfactory to the Issuers on the terms contained in this Agreement. If, within 36 hours after any such default
by any Initial Purchaser, the non-defaulting Initial Purchasers do not arrange for the purchase of such Securities, then the Issuers
shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Initial
Purchasers to purchase such Securities on such terms. If other persons become obligated or agree to purchase the Securities of
a defaulting Initial Purchaser, either the non-defaulting Initial Purchasers or the Issuers may postpone the Closing Date
for up to five full business days in order to effect any changes that in the opinion of counsel for the Issuers or counsel for
the Initial Purchasers may be necessary in the Time of Sale Information, the Offering Memorandum or in any other document or arrangement,
and the Issuers agree to promptly prepare any amendment or supplement to the Time of Sale Information or the Offering Memorandum
that effects any such changes. As used in this Agreement, the term “Initial Purchaser” includes, for all purposes
of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section
10, purchases Securities that a defaulting Initial Purchaser agreed but failed to purchase.

 

(b)         
If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Initial Purchaser or Initial
Purchasers by the non-defaulting Initial Purchasers and the Issuers as provided in paragraph (a) above, the aggregate principal
amount of such Securities that remains unpurchased does not exceed one-eleventh of the aggregate principal amount of all the Securities,
then the Issuers shall have the right to require each non-defaulting Initial Purchaser to purchase the principal amount of Securities
that such Initial Purchaser agreed to purchase hereunder plus such Initial Purchaser’s pro rata share (based on the
principal amount of Securities that such Initial Purchaser agreed to purchase hereunder) of the Securities of such defaulting
Initial Purchaser or Initial Purchasers for which such arrangements have not been made.

 

(c)         
If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Initial Purchaser or Initial
Purchasers by the non-defaulting Initial Purchasers and the Issuers as provided in paragraph (a) above, the aggregate principal
amount of such Securities that remains unpurchased exceeds one-eleventh of the aggregate principal amount of all the Securities,
or if the Issuers shall not exercise the right described in paragraph (b) above, then this Agreement shall terminate without liability
on the part of the non-defaulting Initial Purchasers. Any termination of this Agreement pursuant to this Section 10 shall be without
liability on the part of the Issuers or the Guarantors, except that the Issuers and each of the Guarantors will continue to be
liable for the payment of expenses as set forth in Section 11 hereof and except that the provisions of Section 7 hereof shall
not terminate and shall remain in effect.

 

(d)         
Nothing contained herein shall relieve a defaulting Initial Purchaser of any liability it may have to the Issuers, the
Guarantors or any non-defaulting Initial Purchaser for damages caused by its default.

 

    28

     

    

 

11.       Payment
of Expenses.

 

(a)         
Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Issuers
and the Guarantors jointly and severally agree to pay or cause to be paid all costs and expenses incident to the performance of
their respective obligations hereunder, including without limitation, (i) the costs incident to the authorization, issuance,
sale, preparation and delivery of the Securities and any taxes payable in that connection; (ii) the costs incident to the
preparation and printing of the Preliminary Offering Memorandum, any other Time of Sale Information, any Issuer Written Communication
and the Offering Memorandum (including any amendment or supplement thereto) and the distribution thereof; (iii) the costs
of reproducing and distributing each of the Transaction Documents; (iv) the fees and expenses of the Issuers' and the Guarantors’
counsel and independent accountants; (v) the fees and expenses incurred in connection with the registration or qualification and
determination of eligibility for investment of the Securities under the laws of such jurisdictions as the Representative may designate
and the preparation, printing and distribution of a Blue Sky Memorandum (including the related fees and expenses of counsel for
the Initial Purchasers); (vi) any fees charged by rating agencies for rating the Securities; (vii) the fees and expenses
of the Trustee and any paying agent (including related fees and expenses of any counsel to such parties); (viii) all expenses
and application fees incurred in connection with the approval of the Securities for book-entry transfer by DTC; and (ix) all expenses
incurred by the Issuers in connection with any “road show” presentation to potential investors.

 

(b)         
If (i) this Agreement is terminated pursuant to Section 9, (ii) the Issuers for any reason fail to tender the Securities
for delivery to the Initial Purchasers or (iii) the Initial Purchasers decline to purchase the Securities for any reason permitted
under this Agreement, the Issuers and each of the Guarantors jointly and severally agree to reimburse the Initial Purchasers for
all out-of-pocket costs and expenses (including the fees and expenses of their counsel) reasonably incurred by the Initial Purchasers
in connection with this Agreement and the offering contemplated hereby.

 

12.       Persons
Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the parties hereto and
their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates
of each Initial Purchaser referred to in Section 7 hereof. Nothing in this Agreement is intended or shall be construed to give
any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained
herein. No purchaser of Securities from any Initial Purchaser shall be deemed to be a successor merely by reason of such purchase.

 

13.       Survival.
The respective indemnities, rights of contribution, representations, warranties and agreements of the Issuers, the Guarantors
and the Initial Purchasers contained in this Agreement or made by or on behalf of the Issuers, the Guarantors or the Initial Purchasers
pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the Securities
and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on
behalf of the Issuers, the Guarantors or the Initial Purchasers.

 

14.       Certain
Defined Terms. For purposes of this Agreement, (a) except where otherwise expressly provided, the term “affiliate”
has the meaning set forth in Rule 405 under the Securities Act; (b) the term “business day” means any day other
than a day on which banks are permitted or required to be closed in New York City; (c) the term “subsidiary”
has the meaning set forth in Rule 405 under the Securities Act; (d) the term “Exchange Act” collectively means
the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder; and (e) the term
 “written communication” has the meaning set forth in Rule 405 under the Securities Act.

 

    29

     

    

 

15.       Compliance
with USA Patriot Act. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into
law October 26, 2001)), the Initial Purchasers are required to obtain, verify and record information that identifies their respective
clients, including the Issuers, which information may include the name and address of their respective clients, as well as other
information that will allow the Initial Purchasers to properly identify their respective clients.

 

16.       Miscellaneous.

 

(a)         
Authority of the Representative. Any action by the Initial Purchasers hereunder may be taken by Barclays Capital
Inc. on behalf of the Initial Purchasers, and any such action taken by Barclays Capital Inc. shall be binding upon the Initial
Purchasers.

 

(b)         
Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly
given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Initial Purchasers shall
be given to the Representative c/o Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019 (fax: Syndicate Registration);
Attention: 646-834-8133 (with a copy to Latham & Watkins LLP, 811 Main Street, Houston, Texas, 77002, fax: 713-546-5401, Attention:
Michael J. Chambers). Notices to the Issuers and the Guarantors shall be given to them at Enviva Partners, LP, 7200 Wisconsin
Ave., Suite 1000, Bethesda, MD 20814, (fax: 240-482-3774); Attention: General Counsel (with a copy to Vinson & Elkins L.L.P.,
1001 Fannin Street, Houston, Texas, 77002, fax: 713-758-2236, Attention: Ramey Layne).

 

(c)         
Governing Law. This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall
be governed by and construed in accordance with the laws of the State of New York.

 

(d)         
Submission to Jurisdiction. The Issuers and each of the Guarantors hereby submit to the exclusive jurisdiction of
the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising
out of or relating to this Agreement or the transactions contemplated hereby. The Issuers and each of the Guarantors waive any
objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. Each of the
Issuers and each of the Guarantors agrees that final judgment in any such suit, action or proceeding brought in such court shall
be conclusive and binding upon the Issuers and each Guarantor, as applicable, and may be enforced in any court to the jurisdiction
of which Issuers and each Guarantor, as applicable, is subject by a suit upon such judgment.

 

(e)         
Waiver of Jury Trial. Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding
arising out of or relating to this Agreement.

  

    30

     

    

 

(f)          
 Counterparts. This Agreement may be signed in counterparts (which may include counterparts delivered by any standard
form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument.

 

(g)         
Amendments or Waivers. No amendment or waiver of any provision of this Agreement, nor any consent or approval to
any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto.

 

(h)         
Headings. The headings herein are included for convenience of reference only and are not intended to be part of,
or to affect the meaning or interpretation of, this Agreement.

 

		(i)	Recognition of the U.S. Special Resolution Regimes.

 

i.       
In the event that any Initial Purchaser that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution
Regime, the transfer from such Initial Purchaser of this Agreement, and any interest and obligation in or under this Agreement,
will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement,
and any such interest and obligation, were governed by the laws of the United States or a state of the United States.

 

ii.       
In the event that any Initial Purchaser that is a Covered Entity or a BHC Act Affiliate of such Initial Purchaser becomes
subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against
such Initial Purchaser are permitted to be exercised to no greater extent than such Default Rights could be exercised under the
U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.

 

As used in this Section 16(i):

 

“BHC Act Affiliate”
has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. §
1841(k).

 

“Covered Entity” means any of the
following:

 

		i.	a “covered entity”
                                         as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);

 

		ii.	a “covered bank”
                                         as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b);
                                         or

 

		iii.	a “covered FSI”
                                         as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).

  

    31

     

    

 

“Default Right” has
the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1,
as applicable.

 

“U.S. Special Resolution
Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II
of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.

  

    32

     

    

 

If the foregoing is in accordance
with your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.

 

	 	Very truly yours,
	 	 
	 	ENVIVA PARTNERS, LP
	 	 
	 	By:	Enviva Partners GP, LLC,
	 	as its sole general partner
	 	 
	 	By:	/s/ Shai
    Even
	 	 	Name: 	Shai Even
	 	 	Title:	Executive Vice President and Chief Financial
    Officer
	 	 
	 	Enviva Partners
    Finance Corp.
	 	 
	 	By:	/s/ Shai
    Even
	 	 	Name: 	Shai Even
	 	 	Title:	Executive Vice President and Chief
    Financial Officer
	 	 
	 	Enviva gp, llc
	 	 
	 	By:	/s/ Shai
    Even
	 	 	Name:	Shai Even
	 	 	Title:	Executive Vice President and Chief Financial
    Officer
	 	 
	 	Enviva, LP
	 	 
	 	By:	Enviva GP, LLC, as its sole general partner
	 	 
	 	By:	/s/ Shai
    Even
	 	 	Name:	Shai Even
	 	 	Title:	Executive Vice President and Chief Financial
    Officer

  

    33

     

    

 

	 	Enviva Pellets Ahoskie, LLC
	 	 
	 	By:	/s/ Shai Even
	 	 	Name:	Shai Even
	 	 	Title:	Executive Vice President and Chief Financial Officer
	 	 
	 	Enviva Pellets Amory, LLC
	 	 
	 	By:	/s/ Shai Even
	 	 	Name:	Shai Even
	 	 	Title:	Executive Vice President and Chief Financial Officer
	 	 
	 	Enviva Pellets Northampton, LLC
	 	 
	 	By:	/s/ Shai Even
	 	 	Name:	Shai Even
	 	 	Title:	Executive Vice President and Chief Financial Officer
	 	 
	 	Enviva Pellets Southampton, LLC
	 	 
	 	By:	/s/ Shai Even
	 	 	Name:	Shai Even
	 	 	Title:	Executive Vice President and Chief Financial Officer
	 	 
	 	Enviva Pellets SAMPSON, LLC
	 	 
	 	By:	/s/ Shai Even
	 	 	Name: 	Shai Even
	 	 	Title:	Executive Vice President and Chief Financial Officer

 

    34

     

    

  

	 	Enviva
    Pellets Cottondale, LLC
	 	 
	 	By:	/s/
    Shai Even 
	 	 	Name:	Shai
    Even
	 	 	Title:	Executive
    Vice President and Chief Financial Officer

 

	 	Enviva
    Energy Services, LLC
	 	 
	 	By:	/s/
    Shai Even 
	 	 	Name:	Shai
    Even
	 	 	Title:	Executive
    Vice President and Chief Financial Officer
	 	 
	 	Enviva
    PORT OF WILMINGTON, LLC
	 	 
	 	By:	/s/
    Shai Even 
	 	 	Name:	Shai
    Even
	 	 	Title:	Executive
    Vice President and Chief Financial Officer
	 	 
	 	Enviva
    PORT OF PANAMA CITY, LLC
	 	 
	 	By:	/s/
    Shai Even 
	 	 	Name:	Shai
    Even
	 	 	Title:	Executive
    Vice President and Chief Financial Officer
	 	 
	 	Enviva
    Port of Chesapeake, LLC
	 	 
	 	By:	/s/
    Shai Even 
	 	 	Name:	Shai
    Even
	 	 	Title:	Executive
    Vice President and Chief Financial Officer

  

    35

     

    

  

Accepted:
As of the date first written above

 

BARCLAYS
CAPITAL INC.

 

For
itself and on behalf of the

several
Initial Purchasers listed

in
Schedule 1 hereto.

  

	 	 
	By:	/s/ Kevin
    Crealese                    	 
	 	Authorized
    Signatory	 
	 	 

 

  SIGNATURE
PAGE TO

PURCHASE
AGREEMENT

 

    36

     

    

  

	 	 	Schedule 1	 
	 	 	 	 
	Initial Purchaser	 	Principal
    Amount	 
	Barclays Capital Inc.	 	$	37,464,000	 
	BMO Capital Markets Corp.	 	 	18,731,000	 
	Citigroup Global Markets Inc.	 	 	18,731,000	 
	Goldman, Sachs & Co. LLC	 	 	18,731,000	 
	HSBC Securities (USA) Inc.	 	 	18,731,000	 
	J.P. Morgan Securities LLC	 	 	18,731,000	 
	RBC Capital Markets, LLC	 	 	18,731,000	 
	Riverstone Capital Services LLC	 	 	150,000	 
	Total	 	$	150,000,000	 

 

    37

     

    

 

	 	Schedule
    2

 

Guarantors

Entity
Name

 

Enviva
GP, LLC

Enviva,
LP

Enviva
Pellets Southampton, LLC

Enviva
Pellets Northampton, LLC

Enviva
Energy Services, LLC

Enviva
Pellets Amory, LLC

Enviva
Pellets Cottondale, LLC

Enviva
Pellets Ahoskie, LLC

Enviva
Port of Wilmington, LLC

Enviva
Port of Panama City, LLC

Enviva
Pellets Sampson, LLC

Enviva
Port of Chesapeake, LLC

 

    38

     

    

 

 

	 	Schedule
    3

 

Subsidiaries

 

	Entity
    Name	Jurisdiction
    of Formation
	Enviva GP,
    LLC	Delaware
	Enviva, LP	Delaware
	Enviva Partners
    Finance Corp.	Delaware
	Enviva Pellets
    Ahoskie, LLC	Delaware
	Enviva Pellets
    Amory, LLC	Delaware
	Enviva Pellets
    Northampton, LLC	Delaware
	Enviva Pellets
    Southampton, LLC	Delaware
	Enviva Port
    of Chesapeake, LLC	Delaware
	Enviva Pellets
    Cottondale, LLC	Delaware
	Enviva Energy
    Services, LLC	Delaware
	Enviva Port
    of Wilmington, LLC	Delaware
	Enviva Pellets
    Sampson, LLC	Delaware
	Enviva Port
    of Panama City, LLC	Delaware
	Enviva Wilmington
    Holdings, LLC	Delaware
	Enviva Pellets
    Hamlet, LLC	Delaware
	Enviva Energy
    Services Cooperatief, U.A.	Netherlands
	Enviva Energy
    Services (Jersey), Limited	Jersey
	Enviva MLP
    International Holdings, LLC	Delaware

 

    39

     

    

  

ANNEX
A

 

Additional
Time of Sale Information

 

1.       Term
sheet containing the terms of the Securities, substantially in the form of Annex B.

  

    40

     

    

 

ANNEX
B

  

Term
Sheet

 

 

 

 

 

Enviva Partners, LP

Enviva Partners Finance Corp.

 

$150,000,000 6.500% Senior Notes due
2026

 

June 29, 2020

 

PRICING SUPPLEMENT

 

	This Pricing Supplement, dated June
        29, 2020, is qualified (except as set forth below) in its entirety by reference to the Preliminary Offering Memorandum
        dated June 29, 2020 of Enviva Partners, LP and Enviva Partners Finance Corp. (the “Issuers”), and should be
        read in conjunction with the Preliminary Offering Memorandum. The information in this Pricing Supplement supplements the
        Preliminary Offering Memorandum and supersedes the information therein to the extent it is inconsistent with the information
        in the Preliminary Offering Memorandum. Capitalized terms used in this Pricing Supplement but not defined have the meanings
        given them in the Preliminary Offering Memorandum.

          

        The notes have not been registered
        under the Securities Act of 1933, as amended, or the securities laws of any other jurisdiction. The notes may not be offered
        or sold in the United States or to U.S. persons (as defined in Regulation S) except in transactions exempt from, or not
        subject to, the registration requirements of the Securities Act. Accordingly, the notes are being offered only to (1)
        “qualified institutional buyers” as defined in Rule 144A under the Securities Act and (2) outside the United
        States to non-U.S. persons in compliance with Regulation S under the Securities Act.

         

	Issuers	Enviva Partners, LP

        Enviva Partners Finance Corp.

	Title of Securities	6.500% Senior Notes due 2026 (the “new
    notes”).  The new notes are being offered as additional notes under an indenture pursuant to which the Issuers
    previously issued $600,000,000 aggregate principal amount of the Issuers’ 6.500% Senior Notes Due 2026 (the “initial
    notes”).
	Aggregate Principal Amount	$150,000,000
	Distribution	144A/Regulation S 
	Maturity Date	January 15, 2026
	Offer Price	103.75%, plus accrued interest from July 15,
    2020, if any
	Coupon	6.500%
	Yield to Worst	5.261%
	Benchmark Treasury	UST 2.625% due December 31, 2025 

  

    41

     

     

	Interest Payment Dates	July 15 and January 15 of each
    year, beginning on January 15, 2021
	Record Dates	July 1 and January 1 of each year
	Ratings*	B1 (Moody’s) / B+ (S&P)
    / BB- (Fitch)
	Trade Date	June 29, 2020
	Settlement Date	July 15, 2020 (T+11)

         

        It is expected that delivery of the new notes will
        be made against payment therefor on or about July 15, 2020, which is the eleventh business day following the date hereof
        (such settlement cycle being referred to as “T+11”). Under Rule 15c6-1 under the Exchange Act, trades in the
        secondary market generally are required to settle in two business days unless the parties to any such trade expressly
        agree otherwise. Accordingly, purchasers who wish to trade the new notes on the date of pricing or the next eight succeeding
        business days will be required, by virtue of the fact that the new notes initially will settle in T+11, to specify an
        alternative settlement cycle at the time of any such trade to prevent a failed settlement. Purchasers of the new notes
        who wish to trade the new notes on the date of pricing or the next eight business days should consult their own advisors.

         

	Optional Redemption	On or after the following dates and at the following redemption
    prices (expressed as percentages of principal amount), plus accrued and unpaid interest, if redeemed during the twelve-month
    period beginning on November 15 of the years indicated below:
	 	Year	Price
	 	2021       

        2022

        2023 and thereafter

         
	103.250%
	101.625%
	100.000%
	 
	Make-Whole Redemption	Prior to November 15, 2021, make-whole at T+50 bps
	Equity Clawback	Up to 35% at 106.500% prior to
    November 15, 2021
	Change of Control	101% plus accrued and unpaid interest
    

 

 

    42

     

     

	Joint
    Book-Running Managers	Barclays Capital Inc.

        BMO Capital Markets Corp.

        Citigroup Global Markets Inc.

        Goldman Sachs & Co. LLC

        HSBC Securities (USA) Inc.

        J.P. Morgan Securities LLC

        RBC Capital Markets, LLC

	Co-Manager	Riverstone Capital Services LLC
	Temporary Regulation S CUSIP/ISIN Numbers	U2937RAD3 / USU2937RAD36

        The new notes will have the same CUSIP and ISIN numbers
        as, and will trade together with, the initial notes, except that the new notes issued in offshore transactions under Regulation
        S shall be issued and maintained under a temporary CUSIP number during a 40-day distribution compliance period commencing
        on the issue date of the new notes.

         

	CUSIP Numbers	Rule 144A: 29413XAD9

        Regulation S: U2937RAB7 (Permanent)

         

	ISIN Numbers	Rule 144A: US29413XAD93

        Regulation S: USU2937RAB79 (Permanent)

         

	Denominations	Minimum denominations of $2,000 and integral
    multiples of $1,000 in excess thereof
	Use of Proceeds	We estimate that we will receive net proceeds
    of approximately $152.9 million from this offering after deducting initial purchasers’ discounts and commissions and
    our estimated offering expenses.  We intend to use the net proceeds of this offering (along with the net proceeds
    from the Private Placement), to fund a portion of the cash consideration for each of the Acquisitions, to repay borrowings
    under our senior secured revolving credit facility and for general partnership purposes.

 

 

 

 

This material is
confidential and is for your information only and is not intended to be used by anyone other than you. This information does not
purport to be a complete description of these new notes or the offering. Please refer to the Preliminary Offering Memorandum for
a complete description. 

 

This communication
is being distributed in the United States solely to Qualified Institutional Buyers, as defined in Rule 144A under the Securities
Act of 1933, as amended, and outside the United States solely to Non-U.S. persons as defined under Regulation S.

 

This communication
does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction to any person to
whom it is unlawful to make such offer or solicitation in such jurisdiction.

 

 

    43

     

     

*A securities rating
is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

 

Any disclaimer or other
notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was
automatically generated as a result of this communication being sent by Bloomberg or another email system.

  

    44

     

    

  

ANNEX
C

 

Restrictions
on Offers and Sales Outside the United States

 

In
connection with offers and sales of Securities outside the United States:

 

(a)       Each
Initial Purchaser acknowledges that the Securities have not been registered under the Securities Act and may not be offered or
sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in
transactions not subject to, the registration requirements of the Securities Act.

 

(b)       Each
Initial Purchaser, severally and not jointly, represents, warrants and agrees that:

 

(i)       Such
Initial Purchaser has offered and sold the Securities, and will offer and sell the Securities, (A) as part of their distribution
at any time and (B) otherwise until 40 days after the later of the commencement of the offering of the Securities and the Closing
Date, only in accordance with Regulation S under the Securities Act (“Regulation S”) or Rule 144A or any other
available exemption from registration under the Securities Act.

 

(ii)       None
of such Initial Purchaser or any of its affiliates or any other person acting on its or their behalf has engaged or will engage
in any directed selling efforts with respect to the Securities, and all such persons have complied and will comply with the offering
restrictions requirement of Regulation S.

 

(iii)       At
or prior to the confirmation of sale of any Securities sold in reliance on Regulation S, such Initial Purchaser will have sent
to each distributor, dealer or other person receiving a selling concession, fee or other remuneration that purchases Securities
from it during the distribution compliance period a confirmation or notice to substantially the following effect:

 

The
Securities covered hereby have not been registered under the U.S. Securities Act of 1933, as amended (the “Securities
Act”), and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons
(i) as part of their distribution at any time or (ii) otherwise until 40 days after the later of the commencement of the offering
of the Securities and the date of original issuance of the Securities, except in accordance with Regulation S or Rule 144A or
any other available exemption from registration under the Securities Act. Terms used above have the meanings given to them by
Regulation S.

 

    45

     

    

 

(iv)       Such
Initial Purchaser has not and will not enter into any contractual arrangement with any distributor with respect to the distribution
of the Securities, except with its affiliates or with the prior written consent of the Partnership.

 

Terms
used in paragraph (a) and this paragraph (b) and not otherwise defined in this Agreement have the meanings given to them by Regulation
S.

 

(c)       Each
Initial Purchaser acknowledges that no action has been or will be taken by the Issuers that would permit a public offering of
the Securities, or possession or distribution of any of the Time of Sale Information, the Offering Memorandum, any Issuer Written
Communication or any other offering or publicity material relating to the Securities, in any country or jurisdiction where action
for that purpose is required.

  

    46

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]